Infectious Diseases

Latest MedTech News and Updates for Abbott, Philips and HOYA

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Abbott’s Alinity m STI Assay; Phillips’ MR 7700 System; HOYA’s MiYOSMART Spectacle Lens; Magneto’s Pulmonary Embolism Treatment; Owen Mumford and Stevanto Group’s Collaboration Deal; Elekta’s Radiosurgery System-Elekta Esprit

Abbott Receives Regulatory Approval from US FDA for Alinity™ m STI Assay On May 04, 2022, the US Food and Drug Administration (FDA) granted the regulatory approval to Alinity™ m STI Assay developed by Abbott which is capable of simultaneously detecting and differentiating four common sexually transmitted infections (STIs). It is a first-of-its-kind multiplex test that will help address increasing STI rates which were attributed to the disruptions in delivery of care during the pandemic contributed that led to a decline in routine STI screening and an increase in cases. The Alinity m STI test tests for four microorganisms namely Chlamydia t...

Explore More...

Latest-pharma-happenings-for-hepion-nimbus-regeneron-bicycle-therapeutics

Hepion aces mid-stage study; Bicycle Therapeutics-Ionis collaboration; Nimbus raises $105M; Regeneron to support ISA Pharma

pharma-happenings-for-jnj-bayer-novo-prothena

Bayer’s CKD Drug; Enochian’s RNA Hijack for HBV; Novo Nordisk’s to get Prothena’s ATTR Amyloidosis Business; J&J’s COVID-19 Vaccine Struggle

Charting out the COVID-19 Vaccine Landscape

pharma-happenings-for-arrowhead-sartorius-sirnaomics-agc-biologics

Arrowhead’s ARO-ENaC Clinical Trial; Sartorius Acquires Stake in CellGenix; AGC Biologics’s Cell & Gene Therapy; Sirnaomics Secures $105 Million

Another Failed NASH Drug; Takeda’s Dengue Shot; Innovent’s Cholangiocarcinoma Clinical Trial; TLX66 in AL Amyloidosis

TLX66 in AL Amyloidosis; Takeda’s Dengue Shot; Innovent’s Cholangiocarcinoma Clinical Trial; Another Failed NASH Drug

Pharma Companies Foray into the ABSSSI Market to Develop Novel Antibiotics and Tackle Antibiotic Resistance

recent-pharma-news-updates-for-artios-scholar-rock-novavax-volastra

Artios collaborates with Novartis; Scholar Rock eyes Phase III trial; Novavax starts crossover arms in Covid-19 trials; Volastra nabs $44M

e-pharmacy-online-medicine-benefit-drawbacks-challenges-market-and-trends-analysis

E-Pharmacies: A Disruptive Innovation and the Future of Pharma Sector

Evotec, Takeda Deal; AZ COVID Vaccine US Trials; Promega’s Recognition; Roche’s Tecentriq Results in NSCLC

pharma-happenings-for-gbt-sanofi-eli-lilly-glooko-solid-biosciences

GBT strikes a deal with Sanofi; Lilly’s IL-23 inhibitor shows promise; Glooko raises $30M; FDA uplifts hold on Solid’s DMD gene therapy

Merck, Gilead teams up for HIV treatment; Bright Future for Sanofi/Regeneron’s Libtayo; Roche acquires GenMark; FDA okays Melinta’s Kimyrsa

recent-pharma-happenings-for-Pfizer AbbVie Novavax Iktos Pfizer

Novavax targets COVID-19 approval; Iktos collaborates with Pfizer; AbbVie bags option to acquire Mitokinin; Presage inks new pact with Merck

applications-and-use-of-artificial-intelligence-in-healthcare-pharmaceutical-medical-lifescience-biotechnology-industry

Applications of AI in Healthcare: COVID-19 and Beyond

recent-pharma-happenings-for-bluebird-pfizer-guardant-astrazeneca

Bluebird suspends gene therapy trials; Cortexyme tripped up by FDA hold; Guardant Health launches surveillance blood test; Enhertu scores approval

Smoking Cessation Market | Quitting Tobacco | Nicotine-addiction |

The Mesh of the Generics and the Potential of Emerging Therapies in the Smoking Cessation Market

recent-pharma-biotech-happenings-for-bms-prothena-canon-medical-immunovant

Plaque psoriasis drug outshines in phase III trial; Immunovant announces pause in trial of IMVT-1401; Prothena brings AL amyloidosis drug back; Canon Medical expands its MRI AI programs

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective